Cargando…
Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) st...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465350/ https://www.ncbi.nlm.nih.gov/pubmed/30988344 http://dx.doi.org/10.1038/s41598-019-42365-w |
_version_ | 1783410927168651264 |
---|---|
author | Hirabayashi, Mayo Inoue, Manami Sawada, Norie Saito, Eiko Abe, Sarah K. Hidaka, Akihisa Iwasaki, Motoki Yamaji, Taiki Shimazu, Taichi Tsugane, Shoichiro |
author_facet | Hirabayashi, Mayo Inoue, Manami Sawada, Norie Saito, Eiko Abe, Sarah K. Hidaka, Akihisa Iwasaki, Motoki Yamaji, Taiki Shimazu, Taichi Tsugane, Shoichiro |
author_sort | Hirabayashi, Mayo |
collection | PubMed |
description | Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) status were determined serologically, using blood sample collected during health checkups. A total of 20,116 subjects enrolled in the Japan Public Health Center-based Prospective Study Cohort II with available data on H. pylori seropositivity (anti-H. pylori) and AG were followed until the end of 2010. Cox proportional hazards models were used to calculate the hazard ratios (HR) and 95% confidence intervals (CI), using the information from the baseline survey. During 320,470 person-years of follow-up, 119 cases of pancreatic cancer were identified. No statically significant increase or decrease in pancreatic cancer risk was observed for H. pylori and AG status, independently or in combination. In a multivariable-adjusted model, we observed a non-significant decrease in the risk among those who had AG but were anti-H. pylori seronegative (HR 0.57, 95% CI 0.31–1.03). In a stratified analysis, we observed a statistically significant increased risk of pancreatic cancer for AG+ (HR 3.64, 95% CI 1.37–9.66), and AG+/anti-H. pylori− or AG+/anti-H. pylori+ (HR 5.21, 95% CI 1.14–23.87) among current smokers. Non-smokers in all categories of AG and anti-H. pylori showed a non-statistical decrease in the risk. There was no statistically significant interaction between H. pylori infection, AG status, and smoking status. Our findings suggest H. pylori seropositivity and AG, individually or in combination, are not associated with the risk of pancreatic cancer in a general Japanese population. Among current smokers, pancreatic cancer risk increased with AG, regardless of H. pylori infection status. |
format | Online Article Text |
id | pubmed-6465350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64653502019-04-18 Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study Hirabayashi, Mayo Inoue, Manami Sawada, Norie Saito, Eiko Abe, Sarah K. Hidaka, Akihisa Iwasaki, Motoki Yamaji, Taiki Shimazu, Taichi Tsugane, Shoichiro Sci Rep Article Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) status were determined serologically, using blood sample collected during health checkups. A total of 20,116 subjects enrolled in the Japan Public Health Center-based Prospective Study Cohort II with available data on H. pylori seropositivity (anti-H. pylori) and AG were followed until the end of 2010. Cox proportional hazards models were used to calculate the hazard ratios (HR) and 95% confidence intervals (CI), using the information from the baseline survey. During 320,470 person-years of follow-up, 119 cases of pancreatic cancer were identified. No statically significant increase or decrease in pancreatic cancer risk was observed for H. pylori and AG status, independently or in combination. In a multivariable-adjusted model, we observed a non-significant decrease in the risk among those who had AG but were anti-H. pylori seronegative (HR 0.57, 95% CI 0.31–1.03). In a stratified analysis, we observed a statistically significant increased risk of pancreatic cancer for AG+ (HR 3.64, 95% CI 1.37–9.66), and AG+/anti-H. pylori− or AG+/anti-H. pylori+ (HR 5.21, 95% CI 1.14–23.87) among current smokers. Non-smokers in all categories of AG and anti-H. pylori showed a non-statistical decrease in the risk. There was no statistically significant interaction between H. pylori infection, AG status, and smoking status. Our findings suggest H. pylori seropositivity and AG, individually or in combination, are not associated with the risk of pancreatic cancer in a general Japanese population. Among current smokers, pancreatic cancer risk increased with AG, regardless of H. pylori infection status. Nature Publishing Group UK 2019-04-15 /pmc/articles/PMC6465350/ /pubmed/30988344 http://dx.doi.org/10.1038/s41598-019-42365-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Hirabayashi, Mayo Inoue, Manami Sawada, Norie Saito, Eiko Abe, Sarah K. Hidaka, Akihisa Iwasaki, Motoki Yamaji, Taiki Shimazu, Taichi Tsugane, Shoichiro Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study |
title | Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study |
title_full | Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study |
title_fullStr | Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study |
title_full_unstemmed | Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study |
title_short | Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study |
title_sort | helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: a population-based cohort study in a large japanese population: the jphc study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465350/ https://www.ncbi.nlm.nih.gov/pubmed/30988344 http://dx.doi.org/10.1038/s41598-019-42365-w |
work_keys_str_mv | AT hirabayashimayo helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT inouemanami helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT sawadanorie helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT saitoeiko helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT abesarahk helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT hidakaakihisa helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT iwasakimotoki helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT yamajitaiki helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT shimazutaichi helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy AT tsuganeshoichiro helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy |